Chromatography could be a valuable tool notably within the pharmaceutical and biotechnology sectors because it will give sensitive info concerning product quality and purity. The implementation of method analytical technology has conjointly given a lift to the current market. The growing demands of biopharmaceuticals, notably being antibodies, biosimilar medicine et al. have conjointly necessitated biotechnology and biopharmaceutical industries to take a position in high-throughput bioprocessing and downstream process instruments. The advances in technology for the event of improved systems, innovative and disposable columns, better-performing resins, and alternative accessories square measure serving to this market to grow considerably.
The cell-based assays market is estimated to reach US$ 24.60 Billion by 2028 at a CAGR of 7% in the given forecast period.
The growth is majorly driven by the growing preference for cell-based assays, increasing research funding, and the growth in the number of drug discovery activities. However, the high cost of instruments and restrictions on reagent use are the major factors restraining the growth of this market.
Market Insights
The global Cell-based Assays market is segregated on the basis of Product as Consumables, Reagents, Assay Kits, Probes & Labels, Microplates, Cell Lines, Instruments, and Services. Based on Types the global Cell-based Assays market is segmented in Reporter Gene Assays, Second Messenger Assays, Cell Growth Assays, Cell Death Assays, and Other Assay Kits. Based on End-User Industry the global Cell-based Assays market is segmented in Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, and Contract Research Organizations.
Based on Application, the global Cell-based Assays market is segmented in Drug Discovery and Development, 1 Toxicity Studies, 2 Pharmacokinetic Studies, 3 Pharmacodynamics Studies, Basic Research, Other Applications.
The global Cell-based Assays market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Cell-based Assays market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Thermo Fisher Scientific Inc. , Danaher Corporation , Becton, Dickinson and Company , Ge Healthcare Life Sciences, Merck KGaA , Lonza Group Ltd. , Perkinelmer, Inc. , Charles River Laboratories, Inc. , Cell Signaling Technology, Inc, Promega Corporation , and others are among the major players in the global Cell-based Assays market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Cell-based Assays Market has been segmented as below:
Cell-based Assays Market, By Product
Cell-based Assays Market, By Types
Cell-based Assays Market, By End-User Industry
Cell-based Assays Market, By Application
Cell-based Assays Market, By Region
Cell-based Assays Market, By Company
The report covers:
Report Scope:
The global Cell-based Assays market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Cell-based Assays market share. Major industry players with significant revenue share include Thermo Fisher Scientific Inc. , Danaher Corporation , Becton, Dickinson and Company , Ge Healthcare Life Sciences, Merck KGaA , Lonza Group Ltd. , Perkinelmer, Inc. , Charles River Laboratories, Inc. , Cell Signaling Technology, Inc, Promega Corporation , and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Cell-based Assays Market, By Product
5.1 Introduction
5.2 Consumables
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Reagents
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Assay Kits
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Probes & Labels
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Microplates
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Cell Lines
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Instruments
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Services
5.9.1 Market Overview
5.9.2 Market Size and Forecast
6. Cell-based Assays Market, By Types
6.1 Introduction
6.2 Reporter Gene Assays
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Second Messenger Assays
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Cell Growth Assays
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Cell Death Assays
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Other Assay Kits
6.6.1 Market Overview
6.6.2 Market Size and Forecast
7. Cell-based Assays Market, By End-User Industry
7.1 Introduction
7.2 Pharmaceutical & Biotechnology Companies
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Academic & Government Institutes
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Contract Research Organizations
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8. Cell-based Assays Market, By Application
8.1 Introduction
8.2 Drug Discovery and Development
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 1 Toxicity Studies
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 2 Pharmacokinetic Studies
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 3 Pharmacodynamics Studies
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Basic Research
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 Other Applications
8.7.1 Market Overview
8.7.2 Market Size and Forecast
9. Cell-based Assays Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Cell-based Assays, By Product
9.2.2 North America Cell-based Assays, By Types
9.2.3 North America Cell-based Assays, By End-User Industry
9.2.4 North America Cell-based Assays, By Application
9.3 Europe
9.3.1 Europe Cell-based Assays, By Product
9.3.2 Europe Cell-based Assays, By Types
9.3.3 Europe Cell-based Assays, By End-User Industry
9.3.4 Europe Cell-based Assays, By Application
9.4 Asia-Pacific
9.4.1 Asia-Pacific Cell-based Assays, By Product
9.4.2 Asia-Pacific Cell-based Assays, By Types
9.4.3 Asia-Pacific Cell-based Assays, By End-User Industry
9.4.4 Asia-Pacific Cell-based Assays, By Application
9.5 Rest of the World
9.5.1 Rest of the World Cell-based Assays, By Product
9.5.2 Rest of the World Cell-based Assays, By Types
9.5.3 Rest of the World Cell-based Assays, By End-User Industry
9.5.4 Rest of the World Cell-based Assays, By Application
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Danaher Corporation
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Becton, Dickinson and Company
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Ge Healthcare Life Sciences
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Merck KGaA
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Lonza Group Ltd.
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Perkinelmer, Inc.
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Charles River Laboratories, Inc.
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Cell Signaling Technology, Inc
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Promega Corporation
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
The Cell-based Assays Market has been segmented as below:
Cell-based Assays Market, By Product
Cell-based Assays Market, By Types
Cell-based Assays Market, By End-User Industry
Cell-based Assays Market, By Application
Cell-based Assays Market, By Region
Cell-based Assays Market, By Company
